HIV感染后2年内启动抗逆转录病毒治疗与更少病毒性闪燃相关:美国军队HIV自然史研究20余年数据的回顾性分析
该研究基于美国军队HIV自然史研究1996年至2022年数据,纳入1413例稳定抑制性抗逆转录病毒治疗(ART)参与者,分析病毒性闪燃发生率及其与ART启动时机的关系。结果显示,总体闪燃发生率为1.2次/100人年(95%CI:0.9-1.4),感染后24个月内启动ART者相比超过24个月启动者,闪燃风险显著降低。
要点
- 1413例稳定抑制性ART参与者中,88例(6.2%)发生至少一次闪燃,68例(77.3%)仅单次闪燃。
- 总体闪燃发生率为1.2次/100人年(95%CI:0.9-1.4)。
- 感染后24个月内启动ART与闪燃风险降低独立相关(0-6个月HR 0.29,95%CI:0.18-0.48)。
核心结论
- HIV感染后2年内启动ART的参与者闪燃风险更低,可能反映更小的病毒储存库,提示储存库可塑性延伸至急性期之后。
研究设计与样本
- 美国军队HIV自然史研究(US Military HIV Natural History Study)的回顾性分析,纳入1996年至2022年1413例有估计HIV血清转换日期、启动ART后1年内病毒抑制≤400 copies/mL且抑制后至少3次HIV RNA检测的参与者。
主要发现
- 1413例参与者中88例(6.2%)发生至少一次闪燃,其中68例(77.3%)仅单次闪燃,总体闪燃发生率为1.2次/100人年(95%CI:0.9-1.4)。
- 多变量模型中,相比ART启动超过24个月,感染后0-6个月启动ART的闪燃风险HR为0.29(95%CI:0.18-0.48),6-12个月HR为0.43(95%CI:0.31-0.59),12-24个月HR为0.46(95%CI:0.35-0.60)。
关键数值与推荐
- 闪燃定义为HIV RNA 401-1000 copies/mL,且前后HIV RNA≤400 copies/mL,未改变ART方案。
- 病毒抑制定义为启动ART后1年内HIV RNA≤400 copies/mL。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Viral blips have been associated with larger reservoir size and slower decay. Earlier antiretroviral therapy (ART) initiation may decrease the risk of blips. METHODS: We analyzed participants from the US Military HIV Natural History Study with an estimated human immunodeficiency virus (HIV) seroconversion date, viral suppression ≤400 copies/mL within 1 year after starting ART, and at least 3 HIV RNA measurements after suppression. A blip was defined as HIV RNA 401-1000 copies/mL preceded and followed by HIV RNA ≤400 copies/mL without changing ART. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for factors potentially associated with the time from viral suppression to first blip. RESULTS: From 1996 through 2022, among 1413 participants on stable suppressive ART, 88 (6.2%) had at least one blip, including 68 (77.3%) with only a single blip. The overall incidence was 1.2 blips per 100 person-years (95% CI: .9-1.4). In multivariable modeling, ART initiation within 24 months of estimated HIV acquisition was independently associated with decreased hazard of viral blips compared with ART initiation after more than 24 months (0-6 months HR: 0.29 and 95% CI: .18-.48; 6-12 months HR: 0.43 and 95% CI: .31-.59; 12-24 months HR: 0.46 and 95% CI: .35-.60). CONCLUSIONS: Participants who initiated ART within 2 years of HIV acquisition had lower hazard of blips, potentially reflecting smaller reservoir size and suggesting reservoir plasticity that extends beyond the acute phase of HIV.
引用
- Crowell TA, Hsieh HC, Wang X, et al. Antiretroviral Therapy Within 2 Years of HIV Acquisition Is Associated With Fewer Viral Blips: A Retrospective Analysis of More Than 20 Years of Data From the US Military HIV Natural History Study. Clin Infect Dis. 2025. PMID: 40059621. doi:10.1093/cid/ciaf103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。